The new indication for rosuvastatin is unlikely to have any significant impact on clinical practices because of questions about its clinical utility.
Ogochukwu C. Molokwu, PharmD, MScMed
Advertisement
Articles by Ogochukwu C. Molokwu, PharmD, MScMed
Advertisement
Latest Updated Articles
- Statin Therapy for Elevated hsCRP: More Evidence Is Needed
August 11th 2010
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care
3
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
4
FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies
5